Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.

SARS-CoV-2, a novel coronavirus (CoV) that causes COVID-19, has recently emerged causing an ongoing outbreak of viral pneumonia around the world. While distinct from SARS-CoV, both group 2B CoVs share similar genome organization, origins to bat CoVs, and an arsenal of immune antagonists. In this rep...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:bioRxiv
Autors principals: Lokugamage, Kumari G., Hage, Adam, de Vries, Maren, Valero-Jimenez, Ana M., Schindewolf, Craig, Dittmann, Meike, Rajsbaum, Ricardo, Menachery, Vineet D.
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239075/
https://ncbi.nlm.nih.gov/pubmed/32511335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.03.07.982264
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars